Related Experiment Video
Updated: Jun 20, 2026

05:32
Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph
Published on: February 21, 2025
Evaluation of new data processing algorithms for planar gated ventriculography (MUGA)
Joanna R Fair1, Philip H Heintz1, Robert J Telepak1
1Department of Radiology, University of New Mexico School of Medicine, Albuquerque, New Mexico.
Journal of Applied Clinical Medical Physics
|August 21, 2009
Summary
Before adopting new systems for left ventricular ejection fraction (LVEF) radionuclide gated ventriculogram (MUGA) imaging, a study found significant discrepancies. The new systems did not consistently match existing technology, potentially impacting clinical decisions.
Area of Science:
- Nuclear Medicine
- Cardiovascular Imaging
- Medical Device Evaluation
Background:
- Accurate assessment of left ventricular ejection fraction (LVEF) is crucial for patient management, particularly in oncology.
- Radionuclide gated ventriculography (MUGA) is a standard technique for LVEF measurement.
- Evaluating new imaging systems prior to clinical implementation is essential for maintaining diagnostic accuracy.
Purpose of the Study:
- To compare the accuracy and consistency of two new LVEF radionuclide gated ventriculogram (MUGA) systems against a current standard system.
- To determine the potential clinical impact of discrepancies in LVEF measurements from the new systems.
- To inform the decision regarding the adoption of new MUGA systems at the institution.
Main Methods:
- A parallel study design involving 315 consecutive patients undergoing LVEF assessment.
- Simultaneous acquisition and processing of gamma-camera data using semi-automatic Medasys Pinnacle and fully-automatic/semi-automatic Philips nuclear medicine computer systems.
- Comparative analysis of LVEF results between the Medasys and Philips systems.
Main Results:
- The Philips systems achieved LVEF results within +/- 5 percentage points of the Medasys system in less than 50% of studies.
- Significant deviations in LVEF values were observed between the new Philips systems and the established Medasys system.
- Potential changes in clinical decisions for chemotherapy in cancer patients were identified in 17% of studies due to LVEF discrepancies.
Conclusions:
- Neither of the new LVEF MUGA systems demonstrated sufficient accuracy and consistency for implementation.
- Discrepancies in LVEF measurements could have led to altered clinical management, particularly in cancer patient chemotherapy.
- The institution decided against adopting the evaluated Philips MUGA systems based on the study findings.

